Effects of adenovirus-mediated human cyclooxygenase-2 antisense RNA on the growth of hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 11, Issue 39, 2005, Pages 6110-6114

  Wang, Xiao Hu ^a   Li, Sheng Bao ^a   Tong, Qiang ^a   Xie, Guo Jian ^a   Wu, Qing Ming ^a  

^a HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Adenovirus; Antisense RNA; Cyclooxygenase 2; Hepatocellular carcinoma

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY RNA; CYCLOOXYGENASE 2;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FLOW CYTOMETRY; GENETIC CODE; GENETIC ENGINEERING; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; NONHUMAN; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; VIRUS TITRATION;

EID: 30644459853     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i39.6110     Document Type: Article

References (26)

1. Giardiello FM, Spannhake EW, DuBois RN, Hylind LM, Robinson CR, Hubbard WC, Hamilton SR, Yang VW. Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis. Dig Dis Sci 1998; 43: 311-316
2. Zhan J, Liu JP, Zhu ZH, Yao HR, Chen CY. Relationship between COX-2 expression and clinicopathological features of colorectal cancers. Chin Med J 2004; 117: 1151-1154
3. Wu QM, Li SB, Wang Q, Wang DH, Li XB, Liu CZ. The expression of cox-2 in esophageal carcinoma and its realation to clinicopathologic characteristic. Shijie Huaren Xiahua Zazhi 2001; 1: 11-14
4. Takahashi T, Kozald K, Yatabe Y, Achiwa H, Hida T. Increased expression of COX-2 in the development of human lung cancers. J Environ Pathol Toxicol Oncol 2002; 21: 177-181
5. Dang CT, Shapiro CL, Hudis CA. Potential role of selective COX-2 inhibitors in cancer management. Oncology 2002; 16 (5 Suppl 4): 30-36
6. Howe LR, Darmenberg AJ. A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer. Semin Oncol 2002; 29 (3 Suppl 11): 111-119
7. Minter HA, Eveson JW, Huntley S, Elder DJ, Hague A. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduces prostaglandin E2 synthesis. Clin Cancer Res 2003; 9: 1885-1897
8. Wu QM, Li SB, Liu CZ, Wang XH, Xie GJ, Yu JP. The effects of adenovirus-mediated human COX-2 antisense RNA on growth of esophageal carcinoma cells. Zhongguo Zhongliu Shengwu Zhiliao Zazhi 2001; 8: 285-289
9. Li SB, Wu QM, Wang Q, Wang XH, Xie GJ. Effects of adenovirus-mediated human cox-2 antisense RNA on synthesis of DNA and proteins in esophageal carcinoma cell line. Shijie Huaren Xiahua Zazhi 2003; 5: 517-521
10. Krajewska M, Krijewski S, Epstein JL, Shabaik A, Sauvageot J, Song K, Kitada S, Reed JC. Immunohistochemical analysis of bcl-2, bax, bcl-x and mcl-1expression in prostate cancers. Am J Pathol 1996; 148: 1567-1576
11. Leung WK, To KF, Go MY, Chan FK, Ng EK, Chung SC, Sung JJ. Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma. Int J Oncol 2003; 23: 1317-1322
12. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998; 93: 705-716
13. Kusumoto H, Machara Y, Anai H, Kusumoto T, Sugimachi K. Potentiation of adriamycin cytotoxicity by dipyridamole against HeLa cells in vitro and sarcoma 180 cells in vivo. Cancer Res 1988; 48: 1208-1212
14. Kakiuchi Y, Tsuji S, Tsujii M, Murata H, Kawai N, Yasumaru M, Kimura A, Komori M, Irie T, Miyoshi E, Sasaki Y, Hayashi N, Kawano S, Hori M. Cyclooxygenase-2 activity altered the cell surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis. Cancer Res 2002; 62: 1567-1572
15. Hamasaki Y, Kitzler J, Hardman R, Nettesheim P, Eling TE. Phorbol ester and epidermal growth factor enhance the expression of two inducible prostaglandin H synthase genes in rat tracheal epithelial cells. Arch Biochem Bioghys 1993; 304: 226-234
16. Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 1993; 268: 9049-9055
17. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostahlandin endoperoxide synthase 2. Cell 1995; 83: 493-450
18. Aoki T, Tsukinoki K, Karakida K, Ota Y, Otsuru M, Kaneko A. Expression of cyclooxygenase-2, Bcl-2 and Ki-67 in pleomorphic adenoma with special reference to tumor proliferation and apoptosis. Oral Onco 2004; 40: 954-959
19. Kawamori T, Rao CV, Seibert K, Reddy BS. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 1998; 58: 409-412
20. Minter HA, Eveson JW, Huntley S, Elder DJ, Hague A. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis. Clin Cancer Res 2003; 9: 1885-1897
21. Grosch S, Tegeder I, Niederberger E, Brautigam L, Geisslinger G. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. FASEB J 2001; 15: 2742-2744
22. Richter M, Weiss M, Weinberger I, Furstenberger G, Marian B. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors. Carcinogenesis 2001; 22: 17-25
23. Koga H, Sakisaka S, Ohishi M, Kawaguchi T, Taniguchi E, Sasatomi K, Harada M, Kusaba T, Tanaka M, Kimura R, Nakashima Y, Nakashima O, Kojiro M, Kurohiji T, Sata M. Expression of cyclocygenase-2 in human hepatocellular carcinoma: relevance to tumor differentiation. Hepatology 1999; 29: 688-696
24. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997; 94: 3336-3340
25. DuBois RN, Shao J, Tsujii M, Sheng H, Beauchamp RD. G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res 1996; 56: 733-737
26. Hung WC, Chang HC, Pan MR, Lee TH, Chuang LY. Induction of p27(KIP1) as a mechanism underlying NS398-induced growth inhibition in human lung cancer cells. Mol Pharmacol 2000; 58: 1398-1403